Roundup lawsuit signed cases refer to legal claims that have been formally accepted by an attorney, meaning the law firm has reviewed your situation and committed to representing you in litigation against Bayer. In 2026, tens of thousands of these signed cases remain in various stages of the legal process, with new claimants still being added every month.
This matters because Bayer has already paid out more than $10 billion to resolve Roundup claims since 2020. But many signed cases are still waiting for resolution, and the path forward depends entirely on where your case sits in the pipeline.
This guide covers everything. Who qualifies, what your signed case actually means, how much money is realistic, and what you should expect in 2026 and beyond.
Roundup Lawsuit Signed Cases: What You Need to Know First
Roundup lawsuit signed cases are individual legal claims that law firms have formally taken on after determining a potential client has a qualifying cancer diagnosis and a history of Roundup exposure. These are not class action memberships. They are individual plaintiff agreements in a mass tort litigation.
The distinction matters. In a class action, one settlement covers everyone equally. In a mass tort like the Roundup litigation, each signed case is evaluated individually. Your payout depends on your specific cancer type, your exposure history, and your medical records.
As of 2026, estimates put the number of unresolved Roundup cases still in the litigation system at anywhere from 30,000 to 60,000 claims, depending on the source. New cases are still being signed by law firms across the country.
| Key Detail | Information |
|---|---|
| Litigation Type | Mass tort, not class action |
| Active Cases (est. 2026) | 30,000 to 60,000 unresolved |
| Primary Defendant | Bayer AG (successor to Monsanto) |
| Total Paid Out to Date | Over $10 billion since 2020 |
| Cancer Primarily Alleged | Non-Hodgkin lymphoma |
The process of signing a case is just the beginning. Signing with an attorney does not mean you will receive money next month. The legal process takes time, and understanding where your case fits is the first step.
What Does It Mean to Have a Signed Roundup Case
Having a signed Roundup case means a law firm has entered into a formal attorney-client agreement with you to pursue a legal claim against Bayer on your behalf. It is the official start of your legal representation, triggered after an intake evaluation determines you meet basic eligibility requirements.
When a firm “signs” your case, they are agreeing to work on contingency. That means no upfront cost to you. The attorney gets paid only if you win or settle.
After signing, several things happen in sequence. Your attorney gathers your medical records, documents your exposure history, and prepares what is called a Plaintiff Fact Sheet. This document is required in the federal MDL and outlines your cancer diagnosis, your Roundup use, and your damages.
What happens after your case is signed:
- Attorney collects medical records showing diagnosis
- Exposure history is documented (years of use, frequency, type of product)
- Plaintiff Fact Sheet is filed with the MDL court
- Case is placed into the litigation queue
- Negotiations or trial placement begin based on case strength
One thing many signed claimants don’t realize: signing with a firm does not automatically mean your case will go to trial. The vast majority of Roundup cases, roughly 95% or more, are expected to resolve through settlement negotiations rather than courtroom verdicts.
Roundup Lawsuit Update 2026: Where Things Stand Right Now
The Roundup lawsuit in 2026 is still very much active. Bayer has not resolved all claims, and new signed cases continue to enter the system. The federal MDL, docketed as MDL 2741 in the Northern District of California, remains the central hub for federally filed cases.
Bayer’s legal strategy has shifted significantly since 2020. After three consecutive jury verdicts totaling in the billions, the company moved to settle large volumes of cases. But Bayer has also pushed for legislative and regulatory protections that would limit future liability, an effort that has faced resistance in Congress.
Key 2026 developments in the Roundup litigation:
- Bayer continues to contest the science linking glyphosate to cancer in court
- The EPA’s position that glyphosate is “not likely to be carcinogenic” remains disputed by plaintiffs
- State court cases continue alongside the federal MDL
- New plaintiffs diagnosed after prior settlement cutoff dates are still eligible to file
- Settlement discussions for remaining unresolved cases are ongoing
Think of the Roundup litigation like a very long freight train. The engine moved forward years ago with early settlements and verdicts. The cars in the back, those are the newer and backlogged signed cases, still working their way to the front.
Key Takeaway: As of 2026, the Roundup litigation is unresolved for tens of thousands of claimants, and both settlements and trials continue to occur.
Roundup Lawsuit Who Qualifies in 2026
People who qualify for the Roundup lawsuit in 2026 must generally meet two conditions: they were exposed to Roundup or a glyphosate-based herbicide, and they developed a qualifying cancer as a result. The most commonly alleged cancer is non-Hodgkin lymphoma, but other lymphatic system cancers have also been included.
Exposure does not require professional or agricultural use. Homeowners who used Roundup for years in their yards have qualified. Farmers, landscapers, groundskeepers, golf course workers, and nursery employees have all had successful claims.
General qualification checklist for 2026:
| Criteria | Requirement |
|---|---|
| Roundup Exposure | Used Roundup or glyphosate product regularly |
| Duration of Use | Typically at least 2 years, more exposure strengthens case |
| Cancer Diagnosis | Non-Hodgkin lymphoma or related hematologic cancer |
| Diagnosis Timing | Diagnosed after exposure, not before |
| Age at Diagnosis | No age restriction, but exposure timing must align |
| Statute of Limitations | Varies by state, most range from 2 to 6 years from diagnosis |
You do not need to have saved receipts or product containers. Attorney firms work with exposure history questionnaires and medical record documentation to build your timeline.
Roundup Non-Hodgkin Lymphoma Lawsuit: The Medical Connection
Non-Hodgkin lymphoma is the cancer most frequently cited in Roundup lawsuits, and the connection between glyphosate and this cancer type is central to every claim. In 2015, the International Agency for Research on Cancer, known as IARC, classified glyphosate as “probably carcinogenic to humans,” placing it in Group 2A.
That IARC classification became the scientific foundation for the lawsuits. Plaintiffs argue that Monsanto, and later Bayer, knew about these risks and failed to warn consumers.
Non-Hodgkin lymphoma is not one single disease. It covers more than 60 different types of blood cancers that affect the lymphatic system. The subtypes most commonly linked to glyphosate exposure in litigation include:
- Diffuse large B-cell lymphoma (DLBCL)
- Follicular lymphoma
- Chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)
- Mantle cell lymphoma
- Marginal zone lymphoma
The strength of your case can depend on which subtype you were diagnosed with, since some have stronger epidemiological connections to glyphosate than others. Your law firm’s experts will weigh in on that when building your case.
Bold Callout: IARC’s 2015 Group 2A classification for glyphosate remains the cornerstone of the scientific argument in every active Roundup case.
Roundup Lawsuit Eligibility 2026: Exact Criteria Explained
Roundup lawsuit eligibility in 2026 is assessed on a case-by-case basis, but there are specific factors that attorneys look at during initial intake. Meeting the basic threshold gets you signed. Meeting more factors makes your case more valuable.
The core eligibility factors have not changed dramatically from prior years. What has changed is that some earlier settlement programs had cutoff dates that excluded new claimants. For those who were diagnosed after those cutoffs, 2026 is still a valid window to file.
Detailed eligibility breakdown:
| Factor | Minimum Threshold | Stronger Case Factors |
|---|---|---|
| Exposure Type | Any Roundup or glyphosate product | Agricultural or occupational exposure |
| Exposure Duration | At least 2 years of use | 10 or more years of regular use |
| Frequency of Exposure | Seasonal or occasional use | Weekly or daily application |
| Cancer Type | Non-Hodgkin lymphoma family | DLBCL, follicular lymphoma |
| Diagnosis Date | After period of Roundup exposure | 5 to 10+ years post-exposure |
| Age | Any age | Younger diagnosis may increase damages |
| Existing Settlement | Not previously settled this claim | N/A |
If you already settled a prior personal injury claim related to Roundup, you may not be eligible to refile. But if you were included in a settlement program and your cancer returned or you developed a new cancer, speak with your attorney about options.
Key Takeaway: The key eligibility factors are exposure duration, cancer type, and diagnosis timing. More exposure over a longer period generally means a stronger case.
Roundup Settlement 2026: Is Bayer Still Paying Out
Yes, Bayer is still paying out Roundup settlements in 2026. The company has resolved hundreds of thousands of individual claims since agreeing to the $10.9 billion settlement framework in 2020. But not all claims were included in that original framework, and new claims continue to be filed and resolved separately.
Bayer has also faced continued legal defeats in state courts, which has pushed the company to maintain its settlement posture rather than take every case to trial.
The settlement landscape in 2026 includes three broad categories of claims:
- Claims resolved under the 2020 settlement framework: These are largely paid out, though some payment disputes and appeals remain
- Claims filed after the 2020 cutoff: These are being negotiated through separate settlement discussions or headed toward trial
- Newly signed cases in 2025 and 2026: These are in early stages and may not resolve until 2027 or later
Bayer has publicly stated it intends to defend itself against claims that don’t meet certain evidentiary thresholds. So while the company is still settling, it is also fighting some cases aggressively. Your attorney’s job is to position your case to maximize leverage in those negotiations.
Bayer Roundup Settlement Amount: What the Numbers Show
The Bayer Roundup settlement amount varies widely depending on case-specific factors, but historical data gives us a useful range. The $10.9 billion settlement framework from 2020 covered approximately 100,000 cases, suggesting an average of roughly $100,000 per case. However, averages can be misleading.
Individual case values in actual settlements have ranged from as low as $5,000 for weak exposure and minor health impacts, to upward of $2 million or more for severe cases with strong documentation.
The three biggest jury verdicts before the global settlement framework give context to the upper end:
| Case | Year | Verdict |
|---|---|---|
| Johnson v. Monsanto | 2018 | $289 million (later reduced to $78 million) |
| Hardeman v. Monsanto | 2019 | $80 million |
| Pilliod v. Monsanto | 2019 | $2 billion (reduced, appealed) |
These verdicts do not represent what the average claimant receives. They represent the ceiling that encourages Bayer to settle before trial.
For cases being resolved in 2026, settlement amounts are shaped by prior precedent but negotiated individually. Newer cases with strong medical documentation and long exposure histories are still attracting significant settlement offers.
Roundup Cancer Lawsuit Payout: Realistic Ranges for Claimants
Roundup cancer lawsuit payouts in 2026 fall into rough tiers based on case strength, cancer severity, and the level of documented exposure. There is no fixed amount, and no two cases pay exactly the same.
The honest truth is that most claimants do not receive multimillion-dollar payouts. Those numbers make headlines, but they represent outlier cases. The realistic range for most settled claims sits between $40,000 and $300,000, depending on case strength.
Estimated payout tiers for 2026 Roundup claimants:
| Case Tier | Description | Estimated Payout Range |
|---|---|---|
| Tier 1 (Strongest) | Long occupational exposure, aggressive cancer, strong documentation | $200,000 to $2,000,000+ |
| Tier 2 (Moderate) | Regular residential or farm use, documented NHL diagnosis | $80,000 to $200,000 |
| Tier 3 (Baseline) | Some exposure, qualifying cancer, limited documentation | $30,000 to $80,000 |
| Tier 4 (Weak) | Minimal exposure, less common cancer type, poor documentation | $5,000 to $30,000 |
Attorney fees in contingency cases typically run between 33% and 40% of the settlement. Litigation costs for medical experts and records retrieval are usually deducted from the gross settlement before the net amount is calculated.
Key Takeaway: Most Roundup claimants settle in the $40,000 to $200,000 range after attorney fees, though outlier cases with exceptional facts can go significantly higher.
Roundup Lawsuit Compensation Per Person: How Amounts Are Calculated
Roundup lawsuit compensation per person is calculated using a points-based or weighted scoring system that most law firms and settlement administrators use internally to evaluate case value. The system is not publicly standardized, but several consistent factors determine where your case lands.
Think of it like insurance adjusters valuing a car after a crash. They use a formula based on damage severity, mileage, condition, and comparable sales. The Roundup case valuation works similarly.
Factors that increase your compensation:
- Longer or more intensive exposure history
- Occupational exposure (agricultural, landscaping, golf course)
- More aggressive cancer subtype
- Younger age at diagnosis
- Documented financial losses from medical bills and lost income
- Emotional distress and diminished quality of life evidence
- Cancer recurrence after treatment
Factors that can reduce your compensation:
- Short or infrequent exposure history
- Other potential causes for the cancer (smoking history, genetic predisposition)
- Delay in seeking medical treatment
- Incomplete or missing medical records
- Prior unrelated cancer diagnoses
Your attorney will work with medical experts and economic damages specialists to build the strongest possible case value before entering settlement negotiations or going to trial.
Glyphosate Cancer Lawsuit 2026: The Science Behind the Claims
The glyphosate cancer lawsuit in 2026 rests on decades of scientific research pointing to a link between glyphosate exposure and non-Hodgkin lymphoma. The most cited evidence comes from the IARC’s 2015 classification, which placed glyphosate in the Group 2A “probably carcinogenic” category based on limited human evidence and sufficient animal evidence.
The EPA has maintained a different position, concluding in its 2020 Interim Registration Review Decision that glyphosate is “not likely to be carcinogenic to humans.” That disagreement between the IARC and EPA is central to the legal battle.
Plaintiffs’ attorneys argue that internal Monsanto documents, revealed during discovery, show the company was aware of cancer risks and worked to discredit independent science. These documents have been introduced as evidence in multiple trials and have influenced jury verdicts.
Scientific evidence timeline:
| Year | Event |
|---|---|
| 1970 | Glyphosate first synthesized by Monsanto |
| 1985 | EPA first classified glyphosate as possible carcinogen (later revised) |
| 2015 | IARC classified glyphosate as Group 2A probable carcinogen |
| 2019 | Hardeman verdict upheld glyphosate-NHL link in federal court |
| 2020 | EPA reaffirmed “not likely carcinogenic” position |
| 2022 | Ninth Circuit ruled EPA’s determination was inadequate, vacated it |
| 2026 | EPA review ongoing; scientific debate continues in courts |
The Ninth Circuit’s 2022 ruling vacating the EPA’s finding is significant. It means Bayer cannot rely on EPA approval as a blanket legal shield in court.
Pending Roundup Cases 2026: What Happens to Backlogged Claims
Pending Roundup cases in 2026 include tens of thousands of signed cases that have not yet received settlement offers or trial dates. These are not forgotten cases. They are working their way through a system that was never designed to handle litigation at this scale.
Mass tort litigation with this many plaintiffs moves in waves. Early cases with the strongest facts and most documented exposure tend to be selected as bellwether trials. Those verdicts set the tone for settlement negotiations across the rest of the docket.
What is happening to pending cases right now:
- Bayer is reviewing cases individually based on submitted Plaintiff Fact Sheets
- Stronger cases are being prioritized for settlement offers
- Weaker or incomplete cases are being returned to law firms for additional documentation
- Some cases are being withdrawn or dismissed due to inability to prove exposure or diagnosis
- A portion of backlogged claims will be placed into a trial pool if no settlement is reached
If your case has been signed but you have not heard anything in over a year, the most likely explanation is that your Plaintiff Fact Sheet is still being processed, or your firm is waiting for Bayer to extend settlement offers to your case tier.
Key Takeaway: Silence from your law firm does not mean your case is dead. Backlogged pending cases are still active and moving through the system, just slowly.
How to File a Roundup Claim 2026: Step-by-Step
Filing a Roundup claim in 2026 starts with a free case evaluation from a mass tort law firm. You don’t go to court yourself. You don’t file paperwork on your own. The attorney handles the litigation process.
Here’s how the process actually works from start to finish:
Step 1: Initial case evaluation
Contact a law firm that handles Roundup cases. They will ask about your cancer diagnosis, your exposure history, and your medical records. This call is free. There is no obligation.
Step 2: Signing the retainer agreement
If the firm believes you have a qualifying case, they will send you a retainer agreement. Signing this document officially makes you a client. This is what it means to have a “signed case.”
Step 3: Medical records collection
Your attorney’s team collects records from your oncologist, primary care doctor, and any cancer treatment centers. These records document your diagnosis and treatment history.
Step 4: Plaintiff Fact Sheet completion
This document is required in the federal MDL. It details your exposure history, product use, diagnosis, and damages. Your attorney prepares it with your input.
Step 5: Case is filed and placed into the litigation queue
Your case is formally filed in the MDL or an applicable state court. From here, you wait for either a settlement offer or a trial assignment.
Step 6: Settlement negotiation or trial
Your attorney negotiates with Bayer’s legal team. If a fair offer is made, you decide whether to accept or proceed to trial.
Roundup Lawsuit Filing Deadline 2026: Do Not Miss This
The Roundup lawsuit filing deadline in 2026 is not a single national date. Statutes of limitations vary by state, and missing your state’s deadline can permanently bar you from filing a claim. This is one of the most important things to understand.
Most states give plaintiffs 2 to 6 years from the date they discovered their cancer to file a claim. The clock typically starts from the date of diagnosis, not from the date of Roundup exposure.
State statute of limitations examples (approximate):
| State | Time Limit from Discovery/Diagnosis |
|---|---|
| California | 2 years |
| Texas | 2 years |
| Florida | 4 years |
| New York | 3 years |
| Illinois | 2 years |
| Pennsylvania | 2 years |
| Ohio | 2 years |
If you were diagnosed in 2022 and you live in a state with a 2-year limit, your window may have already closed unless an exception applies. Discovery rules, the period when you first reasonably could have known that Roundup caused your cancer, can extend the deadline in some jurisdictions.
Do not assume you have more time. The risk of waiting is real.
Roundup Lawsuit Trial Verdicts 2026: Key Outcomes to Know
Roundup lawsuit trial verdicts in 2026 continue to shape the settlement value of pending claims across the entire docket. When juries rule against Bayer, it puts pressure on the company to resolve remaining cases before more verdicts stack up. When Bayer wins, it may use that as leverage to push settlement amounts down.
The history of verdicts shows a pattern that has generally favored plaintiffs in cases that go to trial.
Major Roundup verdict history:
| Case | Court | Year | Original Verdict | Final Amount After Appeal |
|---|---|---|---|---|
| Johnson v. Monsanto | CA State | 2018 | $289M | Reduced to $78M |
| Hardeman v. Monsanto | Federal | 2019 | $80M | Upheld on appeal |
| Pilliod v. Monsanto | CA State | 2019 | $2.05B | Significantly reduced on appeal |
| Various State Court Cases | Multiple | 2021-2025 | Mixed verdicts | Ongoing appeals |
As of 2026, Bayer continues to appeal unfavorable verdicts while simultaneously settling others. This dual-track strategy is common in mass tort litigation of this scale.
New verdicts from 2025 trials are working through the appellate process and may produce final rulings in 2026 or 2027 that influence remaining settlement negotiations significantly.
Key Takeaway: Trial verdicts keep the pressure on Bayer to settle. The string of plaintiff-favorable jury decisions since 2018 remains the most powerful factor driving ongoing settlement activity.
How Long Does a Roundup Lawsuit Take: Honest Timeline Breakdown
A Roundup lawsuit takes anywhere from 1 year to 5 years or more from signing to resolution, depending on case complexity, court backlog, and whether your case settles or goes to trial. There is no guaranteed timeline, and anyone who tells you otherwise is overpromising.
The frustrating reality is that mass tort litigation is a slow process by design. Courts require documentation, medical expert review, deposition schedules, and negotiation windows that simply take time.
Realistic Roundup case timeline:
| Phase | Estimated Duration |
|---|---|
| Case intake and evaluation | 1 to 3 months |
| Signing retainer agreement | Same week as evaluation approval |
| Medical records collection | 1 to 4 months |
| Plaintiff Fact Sheet filing | 1 to 2 months after records collection |
| MDL queue placement and review | 6 to 18 months |
| Settlement negotiation window | 3 to 12 months |
| Settlement payment processing | 3 to 6 months after agreement |
| Trial (if no settlement) | 2 to 5 years from filing |
Cases signed in 2025 and 2026 that enter the MDL pipeline now are unlikely to resolve before 2027 at the earliest. Some may take until 2028 or 2029 if they proceed to trial.
The most practical advice: file as soon as possible to get into the queue. The sooner your case is filed and documented, the sooner you can be positioned for a settlement offer when Bayer opens that window.
Frequently Asked Questions
How much money can I get from a Roundup lawsuit in 2026?
Most Roundup claimants receive between $40,000 and $300,000 after attorney fees and litigation costs.
The exact amount depends on your cancer type, how long you used Roundup, your medical documentation, and how your case is positioned in negotiation.
Outlier cases with strong occupational exposure and aggressive cancer have settled for over $1 million, but these are not typical.
What does it mean when a law firm says my Roundup case is signed?
A signed Roundup case means the law firm has formally accepted you as a client and committed to representing you in litigation against Bayer.
It means you’ve entered a contingency fee agreement, so you pay nothing upfront.
After signing, the firm collects your medical records, documents your exposure history, and files the required court documents to formally place your case into the litigation.
Do I qualify for the Roundup lawsuit if I used it in my backyard?
Yes, residential use of Roundup qualifies as exposure for purposes of the lawsuit.
You don’t need to have been a farmer or professional landscaper. Years of regular backyard use combined with a non-Hodgkin lymphoma diagnosis is a qualifying combination.
The key factors are how long you used it, how frequently, and whether your cancer diagnosis came after that exposure period.
How long does it take to get a Roundup settlement check?
From the time you sign with an attorney to the time a settlement check arrives, the process typically takes 2 to 5 years for most claimants.
Once a settlement is agreed to, payment processing takes an additional 3 to 6 months.
Cases filed earlier in the litigation generally resolve faster than newly signed cases entering the queue in 2025 and 2026.
What type of cancer qualifies for the Roundup lawsuit?
Non-Hodgkin lymphoma is the primary qualifying cancer in Roundup lawsuits.
Within non-Hodgkin lymphoma, qualifying subtypes include diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, and chronic lymphocytic leukemia.
If you were diagnosed with a different cancer, speak with a Roundup attorney directly, as eligibility criteria continue to evolve as new medical evidence is reviewed.
What You Should Do Right Now
If you have a signed Roundup case already, your job right now is simple: stay in communication with your law firm, make sure your medical records are complete and submitted, and be patient with the timeline. The litigation is still active and your case has not been forgotten.
If you have not yet signed with an attorney but you’ve used Roundup for years and been diagnosed with non-Hodgkin lymphoma, act quickly. Statutes of limitations are real, and the window to file is not open forever.
The Roundup litigation is one of the largest mass tort cases in American history. Bayer has already paid billions and is still settling claims. Your signed case is part of that ongoing process.
